# MMEDV (MiniMed Group, Inc.) - SEC EDGAR Financial Statements

> MiniMed Group, Inc. reported $3.10B in revenue and a net loss of $309.0M for the fiscal year ended April 24, 2026 (up 14.3% year over year), with a 54.2% gross margin and a -6.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/MMEDV
- Markdown: https://convexityos.com/fundamentals/MMEDV.md
- SEC CIK: 0002062583
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 20, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002062583&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $3.10B | +14.3% YoY |
| Operating Income | FY 2026 | -$190.0M | -6.1% margin |
| Net Income | FY 2026 | -$309.0M | -10.0% net margin |
| Diluted EPS | FY 2026 | -$1.10 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$420.0M | -13.5% FCF margin |
| Cash & ST Investments | Jul 31, 2026 | $207.0M | Total debt: $59.00M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| **Revenue** | $3.10B | $2.71B | $2.47B |
| Cost of Revenue | $1.42B | $1.19B | $1.03B |
| **Gross Profit** | $1.68B | $1.53B | $1.44B |
| Research & Development | $448.0M | $436.0M | $437.0M |
| Selling, General & Admin | $1.18B | $1.08B | $1.06B |
| **Operating Income** | -$190.0M | -$146.0M | -$69.00M |
| **EBITDA** | -$34.00M | -$3.00M | $60.00M |
| Income Before Tax | -$189.0M | -$147.0M | -$70.00M |
| Income Tax Expense | $128.0M | $52.00M | $38.00M |
| **Net Income** | -$333.0M | -$213.0M | -$112.0M |
| Basic EPS | -$1.30 | -$0.84 | -$0.44 |
| **Diluted EPS** | -$1.30 | -$0.84 | -$0.44 |
| Basic Shares Outstanding | 256.6M | 252.8M | 252.8M |
| Diluted Shares Outstanding | 256.6M | 252.8M | 252.8M |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $843.0M | $837.0M | $790.0M | -- | $723.0M | -- | $687.0M | -- |
| Cost of Revenue | $378.0M | $357.0M | $428.0M | -- | $314.0M | -- | $292.0M | -- |
| **Gross Profit** | $465.0M | $480.0M | $362.0M | -- | $409.0M | -- | $395.0M | -- |
| Research & Development | $115.0M | $99.00M | $114.0M | -- | $125.0M | -- | $112.0M | -- |
| Selling, General & Admin | $312.0M | $299.0M | $309.0M | -- | $283.0M | -- | $268.0M | -- |
| **Operating Income** | $5.00M | -$93.00M | -$100.0M | -- | -$13.00M | -- | $21.00M | -- |
| **EBITDA** | $46.00M | -$54.00M | -- | -- | $26.00M | -- | -- | -- |
| Income Before Tax | $4.00M | -$92.00M | -$99.00M | -- | -$13.00M | -- | $21.00M | -- |
| Income Tax Expense | $4.00M | $93.00M | $12.00M | -- | $3.00M | -- | $28.00M | -- |
| **Net Income** | $0 | -$185.0M | -$119.0M | -$5.00M | -$19.00M | -$168.0M | -$10.00M | -$5.00M |
| Basic EPS | $0.00 | -- | -$0.47 | -- | -$0.08 | -- | -$0.04 | -- |
| **Diluted EPS** | $0.00 | -- | -$0.47 | -- | -$0.08 | -- | -$0.04 | -- |
| Basic Shares Outstanding | 281.0M | -- | 252.8M | -- | 252.8M | -- | 252.8M | -- |
| Diluted Shares Outstanding | 281.0M | -- | 252.8M | -- | 252.8M | -- | 252.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 |
| --- | --- | --- |
| Cash & Cash Equivalents | $298.0M | $11.00M |
| **Cash & Short-Term Investments** | $298.0M | $11.00M |
| Accounts Receivable, Net | $200.0M | $570.0M |
| Inventory | $341.0M | $311.0M |
| Other Current Assets | $54.00M | $48.00M |
| **Total Current Assets** | $1.35B | $939.0M |
| Property, Plant & Equipment, Net | $711.0M | $706.0M |
| Goodwill | $2.26B | $2.25B |
| Intangible Assets | $107.0M | $132.0M |
| Other Non-Current Assets | $147.0M | $150.0M |
| **Total Non-Current Assets** | $3.28B | $3.26B |
| **Total Assets** | $4.63B | $4.20B |
| Accounts Payable | $163.0M | $205.0M |
| Deferred Revenue (Current) | $15.00M | $11.00M |
| Other Current Liabilities | -- | $271.0M |
| **Total Current Liabilities** | $702.0M | $710.0M |
| Deferred Revenue (Non-Current) | $4.00M | $3.00M |
| Other Non-Current Liabilities | $317.0M | $162.0M |
| **Total Non-Current Liabilities** | $317.0M | $161.0M |
| **Total Liabilities** | $1.02B | $871.0M |
| **Total Debt (incl. Leases)** | $53.00M | $67.00M |
| Common Stock | $3.00M | $0 |
| Retained Earnings | -$116.0M | $0 |
| Accumulated Other Comp. Income | -$12.00M | $3.00M |
| **Total Stockholders' Equity** | $3.61B | $3.33B |
| Total Equity | $3.61B | $3.33B |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Apr 2025 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $207.0M | $298.0M | $10.00M | $11.00M |
| **Cash & Short-Term Investments** | $207.0M | $298.0M | $10.00M | $11.00M |
| Accounts Receivable, Net | $180.0M | $200.0M | $653.0M | $570.0M |
| Inventory | $356.0M | $341.0M | $408.0M | $311.0M |
| Other Current Assets | $72.00M | $54.00M | $37.00M | $48.00M |
| **Total Current Assets** | $1.42B | $1.35B | $1.11B | $939.0M |
| Property, Plant & Equipment, Net | $736.0M | $711.0M | $701.0M | $706.0M |
| Goodwill | $2.25B | $2.26B | $2.26B | $2.25B |
| Intangible Assets | $100.0M | $107.0M | $113.0M | $132.0M |
| Other Non-Current Assets | $152.0M | $147.0M | $146.0M | $150.0M |
| **Total Non-Current Assets** | $3.30B | $3.28B | $3.23B | $3.26B |
| **Total Assets** | $4.72B | $4.63B | $4.34B | $4.20B |
| Accounts Payable | $251.0M | $163.0M | $303.0M | $205.0M |
| Deferred Revenue (Current) | $14.00M | $15.00M | $13.00M | $11.00M |
| Other Current Liabilities | -- | -- | $161.0M | $271.0M |
| **Total Current Liabilities** | $782.0M | $702.0M | $696.0M | $710.0M |
| Deferred Revenue (Non-Current) | $5.00M | $4.00M | $4.00M | $3.00M |
| Other Non-Current Liabilities | $316.0M | $317.0M | $184.0M | $162.0M |
| **Total Non-Current Liabilities** | $316.0M | $317.0M | $185.0M | $161.0M |
| **Total Liabilities** | $1.10B | $1.02B | $881.0M | $871.0M |
| **Total Debt (incl. Leases)** | $59.00M | $53.00M | $61.00M | $67.00M |
| Common Stock | $3.00M | $3.00M | -- | $0 |
| Retained Earnings | -$116.0M | -$116.0M | -- | $0 |
| Accumulated Other Comp. Income | -$14.00M | -$12.00M | $14.00M | $3.00M |
| **Total Stockholders' Equity** | $3.62B | $3.61B | $3.46B | $3.33B |
| Total Equity | $3.62B | $3.61B | $3.46B | $3.33B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| Net Income | -$317.0M | -$198.0M | -$107.0M |
| Depreciation & Amortization | $156.0M | $143.0M | $129.0M |
| Stock-Based Compensation | $46.00M | $41.00M | $38.00M |
| Change in Inventory | -$29.00M | -$19.00M | $5.00M |
| **Operating Cash Flow** | -$197.0M | $140.0M | $41.00M |
| Capital Expenditure | -$223.0M | -$193.0M | -$148.0M |
| **Free Cash Flow** | -$420.0M | -$53.00M | -$107.0M |
| Purchases of Investments | $0 | $0 | -$5.00M |
| Sales & Maturities of Investments | $0 | $0 | $11.00M |
| **Investing Cash Flow** | -$233.0M | -$193.0M | -$157.0M |
| **Financing Cash Flow** | $716.0M | $10.00M | $112.0M |
| **Net Change in Cash** | $287.0M | -$43.00M | -$4.00M |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $0 | -$185.0M | -$111.0M | -$5.00M | -$16.00M | -$168.0M | -$7.00M | -$5.00M |
| Depreciation & Amortization | $41.00M | $39.00M | -- | -- | $39.00M | -- | -- | -- |
| Stock-Based Compensation | $10.00M | $8.00M | $11.00M | -- | $9.00M | -- | $11.00M | -- |
| Change in Inventory | -$15.00M | $64.00M | -- | -- | -$30.00M | -- | -- | -- |
| **Operating Cash Flow** | -$49.00M | -$170.0M | -- | -- | -$141.0M | -- | -- | -- |
| Capital Expenditure | -$41.00M | -$56.00M | -- | -- | -$53.00M | -- | -- | -- |
| **Free Cash Flow** | -$90.00M | -$226.0M | -- | -- | -$194.0M | -- | -- | -- |
| **Investing Cash Flow** | -$41.00M | -$56.00M | -- | -- | -$63.00M | -- | -- | -- |
| **Financing Cash Flow** | $0 | $512.0M | -- | -- | $202.0M | -- | -- | -- |
| **Net Change in Cash** | -$91.00M | $287.0M | -- | -- | -$2.00M | -- | -- | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| **Gross Margin** | 54.2% | 56.3% | 58.2% |
| **Operating Margin** | -6.1% | -5.4% | -2.8% |
| **Net Profit Margin** | -10.7% | -7.8% | -4.5% |
| Return on Equity (ROE) | -9.2% | -6.4% | -- |
| Return on Assets (ROA) | -7.2% | -5.1% | -- |
| Current Ratio | 1.92x | 1.32x | -- |
| Quick Ratio | 1.43x | 0.88x | -- |
| Debt to Equity | 0.01x | 0.02x | -- |
| **Revenue Growth (YoY)** | +14.3% | +10.0% | -- |
| Gross Profit Growth (YoY) | +9.9% | +6.4% | -- |
| Operating Cash Flow Growth (YoY) | -240.7% | +241.5% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -8.5% | -9.1% | -9.0% | -- | -- | -6.1% | -- | -- |
| Return on Assets (ROA) | -6.5% | -7.1% | -7.2% | -- | -- | -4.8% | -- | -- |
| Current Ratio | 1.81x | 1.92x | 1.59x | -- | -- | 1.32x | -- | -- |
| Quick Ratio | 1.36x | 1.43x | 1.01x | -- | -- | 0.88x | -- | -- |
| Debt to Equity | 0.02x | 0.01x | 0.02x | -- | -- | 0.02x | -- | -- |
| **Revenue Growth (YoY)** | +16.6% | -- | +15.0% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +13.7% | -- | -8.4% | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -576.2% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
